AmpliSeq for Illumina sequencing solution

Wednesday, 07 February, 2018 | Supplied by: Illumina Australia Pty Ltd


Thermo Fisher Scientific has partnered with Illumina to make the former’s suite of AmpliSeq chemistry products compatible with the latter’s next-generation sequencing (NGS) platforms. The end result, AmpliSeq for Illumina, enables fast, robust, targeted library prep for all Illumina sequencers.

The solution offers a highly multiplexed polymerase chain reaction (PCR)-based workflow for use with targets ranging from a few to hundreds in a single run. Users can prepare DNA or RNA libraries from as little as 1 ng input in just 5 h, with a comprehensive menu of panels and a wide variety of sample types.

Panels are optimised for clinical cancer and genetic disease research applications, and are available as ready-to-use, community or custom panels. AmpliSeq panels can accommodate high-quality samples such as blood, cell culture or fresh frozen tissue, and also challenging samples such as formalin-fixed paraffin-embedded (FFPE) tissue. Users can select from predesigned panels or customise their content for a variety of genomes and flexibility.

AmpliSeq for Illumina sequencing offers high-confidence data to researchers in a wide variety of application areas. The complete workflow, from design to analysis, is supported by Illumina.

Online: www.illumina.com
Phone: 03 9212 9900
Related Products

ALA Scientific Instruments RuFus cell unroofing system for plasma membrane isolation

ALA Scientific Instruments offers RuFus, a complete and user-friendly system for performing cell...

Lonza plateable mouse hepatocytes

Lonza provides plateable mouse hepatocytes from the four most common research mouse strains,...

PEPperPRINT cLIFT peptide microarray platform

At the core of the technology is a laser-based transfer process that is designed to deposit amino...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd